총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Selecta Biosciences, Inc. (SELB), 포함 22 건 매수 및 19 건 매도. 내부자 매수 총액은 $11.69M 내부자 매도 총액은 $3.72M.
최근 활동이 있는 주요 내부자에는 Springer Timothy A, Cox Carrie Smith, Zenner Patrick J. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — SELB
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2024-01-02 |
Springer Timothy A |
10 Percent Owner |
RSU 부여 |
228,000 |
$0.66 |
$149.39K |
228,000 |
| 2024-01-02 |
Cox Carrie Smith |
Director |
RSU 부여 |
248,000 |
$0.66 |
$162.49K |
248,000 |
| 2024-01-02 |
Zenner Patrick J |
Director |
RSU 부여 |
228,000 |
$0.66 |
$149.39K |
228,000 |
| 2024-01-02 |
Barabe Timothy C |
Director |
RSU 부여 |
228,000 |
$0.66 |
$149.39K |
228,000 |
| 2024-01-02 |
Desilva Nishan M |
Director |
RSU 부여 |
178,000 |
- |
- |
185,000 |
| 2024-01-02 |
Sallin Aymeric |
Director |
RSU 부여 |
178,000 |
- |
- |
178,000 |
| 2024-01-02 |
Brunn Carsten |
President and CEO |
RSU 부여 |
4,654,100 |
- |
- |
4,916,056 |
| 2024-01-02 |
Davis Blaine |
Chief Financial Officer |
RSU 부여 |
2,424,000 |
- |
- |
2,424,000 |
| 2024-01-02 |
Kalayoglu Murat |
10 Percent Owner |
RSU 부여 |
228,000 |
$0.66 |
$149.39K |
228,000 |
| 2024-01-02 |
Singer Michael |
10 Percent Owner |
RSU 부여 |
228,000 |
$0.66 |
$149.39K |
228,000 |
| 2024-01-02 |
Jewell Christopher M |
Chief Scientific Officer |
RSU 부여 |
778,200 |
- |
- |
778,200 |
| 2024-01-02 |
Miljkovic Milos |
Chief Medical Officer |
RSU 부여 |
548,200 |
- |
- |
548,200 |
| 2024-01-02 |
Kurtoglu Metin |
Chief Operating Officer |
RSU 부여 |
1,531,000 |
- |
- |
1,531,000 |
| 2023-12-22 |
Singer Michael |
10 Percent Owner |
증여 (지급) |
3,000 |
- |
- |
3,305 |
| 2023-11-15 |
Springer Timothy A |
10 Percent Owner |
RSU 부여 |
24,785 |
$403.47 |
$10M |
24,785 |
| 2023-11-13 |
Springer Timothy A |
10 Percent Owner |
주식 반환 |
6,410 |
$17.47 |
$111.98K |
- |
| 2023-11-13 |
Cox Carrie Smith |
Director |
주식 반환 |
107,500 |
$1.13 |
$121.48K |
- |
| 2023-11-13 |
Zenner Patrick J |
Director |
주식 반환 |
75,000 |
$1.13 |
$84.75K |
- |
| 2023-11-13 |
Barabe Timothy C |
Director |
주식 반환 |
87,500 |
$1.13 |
$98.88K |
- |
| 2023-11-13 |
Myers Scott Dunseth |
Director |
주식 반환 |
87,500 |
$1.13 |
$98.88K |
- |
| 2023-11-13 |
Desilva Nishan M |
Director |
주식 반환 |
75,000 |
$1.13 |
$84.75K |
- |
| 2023-11-13 |
Sallin Aymeric |
Director |
주식 반환 |
75,000 |
$1.13 |
$84.75K |
- |
| 2023-11-13 |
Brunn Carsten |
President and CEO |
주식 반환 |
1,275,000 |
$1.13 |
$1.44M |
- |
| 2023-11-13 |
Davis Blaine |
Chief Financial Officer |
주식 반환 |
1,250,000 |
$1.27 |
$1.59M |
- |
| 2023-11-13 |
Kalayoglu Murat |
10 Percent Owner |
알 수 없음 |
- |
- |
- |
- |
| 2023-11-13 |
Kalayoglu Murat |
10 Percent Owner |
정보 매수 |
620 |
- |
- |
620 |
| 2023-11-13 |
Singer Michael |
10 Percent Owner |
알 수 없음 |
- |
- |
- |
- |
| 2023-11-13 |
Singer Michael |
10 Percent Owner |
기타 (매수) |
210 |
- |
- |
210 |
| 2023-11-13 |
Jewell Christopher M |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2023-11-13 |
Jewell Christopher M |
Chief Scientific Officer |
RSU 부여 |
4,276 |
$107.59 |
$460.05K |
4,276 |
| 2023-11-13 |
Miljkovic Milos |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2023-11-13 |
Miljkovic Milos |
Chief Medical Officer |
RSU 부여 |
2,566 |
$107.59 |
$276.08K |
2,566 |
| 2023-11-13 |
Kurtoglu Metin |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2023-11-13 |
Kurtoglu Metin |
Chief Operations Officer |
RSU 부여 |
428 |
$107.59 |
$46.05K |
428 |
| 2023-11-13 |
Hoge Elizabeth |
10 Percent Owner |
알 수 없음 |
14,755,609 |
- |
- |
- |
| 2023-09-25 |
Traber Peter G |
Chief Medical Officer |
정보 매도 |
705 |
$1.06 |
$747.30 |
451,826 |
| 2023-09-25 |
Brunn Carsten |
President and CEO |
정보 매도 |
2,932 |
$1.06 |
$3.11K |
783,081 |
| 2023-05-31 |
Kishimoto Takashi Kei |
Chief Scientific Officer |
증여 (지급) |
26,500 |
- |
- |
225,316 |
| 2023-05-30 |
Kishimoto Takashi Kei |
Chief Scientific Officer |
증여 (지급) |
43,000 |
- |
- |
278,316 |
| 2023-01-05 |
Traber Peter G |
Chief Medical Officer |
정보 매도 |
20 |
$1.11 |
$22.23 |
446,121 |
| 2023-01-05 |
Johnston Lloyd P. |
Chief Operations Officer |
정보 매도 |
20 |
$1.11 |
$22.21 |
265,515 |
| 2023-01-05 |
Kishimoto Takashi Kei |
Chief Scientific Officer |
정보 매도 |
20 |
$1.11 |
$22.23 |
364,316 |
| 2023-01-05 |
Brunn Carsten |
President and CEO |
정보 매도 |
77 |
$1.12 |
$85.86 |
786,013 |
| 2023-01-04 |
Traber Peter G |
Chief Medical Officer |
정보 매도 |
15 |
$1.14 |
$17.13 |
449,586 |
| 2023-01-04 |
Johnston Lloyd P. |
Chief Operations Officer |
정보 매도 |
11 |
$1.14 |
$12.54 |
268,907 |
| 2023-01-04 |
Kishimoto Takashi Kei |
Chief Scientific Officer |
정보 매도 |
11 |
$1.15 |
$12.60 |
367,708 |
| 2023-01-04 |
Brunn Carsten |
President and CEO |
정보 매도 |
48 |
$1.15 |
$54.96 |
799,486 |
| 2023-01-02 |
Springer Timothy A |
Director |
RSU 부여 |
75,000 |
- |
- |
75,000 |
| 2023-01-02 |
Ando Goran |
Director |
RSU 부여 |
75,000 |
- |
- |
75,000 |
| 2023-01-02 |
Cox Carrie Smith |
Director |
RSU 부여 |
107,500 |
- |
- |
107,500 |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료